Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion type Assertion NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_head.
- NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion description "[BRAF mutation was mainly detected in SSA/P with dysplasia (95%), SSA/P (85%), microvesicular HP (76%), and traditional serrated adenoma (54%), whereas KRAS mutation was present mainly in goblet cell HP (50%) and in tubulovillous adenoma (45%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_provenance.
- NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion evidence source_evidence_literature NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_provenance.
- NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion SIO_000772 22510757 NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_provenance.
- NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion wasDerivedFrom befree-20150227 NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_provenance.
- NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_assertion wasGeneratedBy ECO_0000203 NP527745.RA1YulNneYiyfSGVFdgch6o96VR41osRZoPy4oQ7RghCo130_provenance.